FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating a wide range of inflammatory ophthalmic diseases: bacterial, allergic, infectious allergic: conjunctivitis, blepharitis, keratitis and others. The eye drops contain a sulphanyl amide preparation, dexamethasone and water. The sulphanyl amide preparation is presented by sodium sulphacyl sodium. Additionally, the drops contain boric acid and hydroxypropyl methyl cellulose in the following proportions, wt %: sodium sulphacyl 8.0-12.0; dexamethasone 0.1-0.01; boric acid 0.4-0.6; hydroxypropyl methyl cellulose 0.4-0.6; water - the rest.
EFFECT: using the invention enables higher therapeutic effectiveness of using the declared eye drops ensured by their prolonged action by prolonging a corneal contact of the preparation.
3 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS | 2012 |
|
RU2504372C1 |
OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
EYE DROPS, WHICH HAVE ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTION | 2012 |
|
RU2493823C1 |
OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
Authors
Dates
2014-02-10—Published
2012-09-07—Filed